Structure Database (LMSD)
LMSD: Structure-based search results
| LM_ID | Common Name | Systematic Name | Formula | Mass | Main Class | Sub Class |
|---|---|---|---|---|---|---|
| LMFA04010007 | 7-F4-NeuroP | (4Z,8E)-9-(3,5-dihydroxy-2-((2Z,5Z)- octa-2,5-dien-1-yl)cyclopentyl)-7- hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010027 | ent-7-F4t-NeuroP | (R,4Z,8E)-9-((1R,2S,3S,5R)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010028 | ent-10-epi-7-F4c-NeuroP | (R,4Z,8E)-9-((1R,2R,3S,5R)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010029 | ent-10-epi-7-F4t-NeuroP | (R,4Z,8E)-9-((1S,2S,3S,5R)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010030 | ent-7-F4c-NeuroP | (R,4Z,8E)-9-((1S,2R,3S,5R)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010031 | 7-epi-7-F4c-NeuroP | (R,4Z,8E)-9-((1R,2S,3R,5S)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010032 | 7,10-diepi-7-F4t-NeuroP | (R,4Z,8E)-9-((1R,2R,3R,5S)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010033 | 7,10-diepi-7-F4c-NeuroP | (R,4Z,8E)-9-((1S,2S,3R,5S)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010034 | 7-epi-7-F4t-NeuroP | (R,4Z,8E)-9-((1S,2R,3R,5S)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010035 | ent-7-epi-4-Ft-NeuroP | (S,4Z,8E)-9-((1R,2S,3S,5R)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010036 | ent-7,10-diepi-4-Fc-NeuroP | (S,4Z,8E)-9-((1R,2R,3S,5R)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010037 | ent-7,10-diepi-4-Ft-NeuroP | (S,4Z,8E)-9-((1S,2S,3S,5R)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010038 | ent-7-epi-4-Fc-NeuroP | (S,4Z,8E)-9-((1S,2R,3S,5R)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010039 | 7-F4c-NeuroP | (S,4Z,8E)-9-((1R,2S,3R,5S)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010040 | 10-epi-7-F4t-NeuroP | (S,4Z,8E)-9-((1R,2R,3R,5S)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010041 | 10-epi-7-F4c-NeuroP | (S,4Z,8E)-9-((1S,2S,3R,5S)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010042 | 7-F4t-NeuroP | (S,4Z,8E)-9-((1S,2R,3R,5S)-3,5- dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1- yl)cyclopentyl)-7-hydroxynona-4,8- dienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |